Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Gastric Cancer × 130-nm albumin-bound paclitaxel × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 58 Carcinoma, Non-Small-Cell Lung 32 Breast Neoplasms 27 Triple Negative Breast Neoplasms 22 Neoplasm Metastasis 13 Lung Neoplasms 12 Neoplasms 10 Colorectal Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Ovarian Neoplasms 7 Gallbladder Neoplasms 6 Fallopian Tube Neoplasms 6 Stomach Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Esophageal Squamous Cell Carcinoma 4 Cholangiocarcinoma 4 Carcinoma, Pancreatic Ductal 4 Biliary Tract Neoplasms 4 Adenocarcinoma 4 Neoplasms by Site 3 Metastatic Pancreatic Ductal Adenocarcinoma 3 Head and Neck Neoplasms 3 Gastrointestinal Neoplasms 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Carcinoma 3 Vaccinia 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Pancreatic cancer, adult 2

Interventions

trastuzumab deruxtecan 2 Trastuzumab 2 Oxaliplatin 2 Fluorouracil 2 Cisplatin 2 Capecitabine 2 pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡